Cyadox

CAS : 65884-46-0

Ref. 3D-QCA88446

Informations sur le produit

• Nom: Cyadox
• Synonymes: 3-{(E)-[(E)-(1-hydroxy-4-oxidoquinoxalin-2(1H)-ylidene)methyl]diazenyl}-3-oxopropanenitrile, Acetic acid, 2-cyano-, 2-[(1,4-dioxido-2-quinoxalinyl)methylene]hydrazide, Acetic acid, cyano-, (2-quinoxalinylmethylene)hydrazide, N,N-dioxide, Acetic acid, cyano-, [(1,4-dioxido-2-quinoxalinyl)methylene]hydrazide, Brn 0826894, Ciadox [INN], Ciadoxum, Ciadoxum [INN-Latin], Cyanoacetic acid (2-quinoxalinylmethylene)hydrazide, N(sup 1),N(sup 4)-dioxide, Cyanoacetylhydrazone 2-formylquinoxaline-1,4-dioxide, N'-(2-Chinoxalinylmethylen)cyanacetohydrazid 1,4-dioxid, Unii-Hx312O5Ugn, Vufb 11502

Description

Cyadox is a metal chelate compound that has been shown to have antibacterial efficacy against Gram-positive bacteria. Cyadox binds to fatty acids on the bacterial cell membrane and forms an ionic complex, which results in the disruption of the lipid bilayer and inhibition of protein synthesis. Cyadox has been shown to inhibit epidermal growth factor (EGF) activity in human serum and may be used for the treatment of skin infections. Cyadox also shows genotoxic activity at high concentrations, but not at low concentrations. Cyadox is effective against Gram-positive bacteria and has been used in combination with other antibiotics to treat infections caused by methicillin-resistant Staphylococcus aureus (MRSA). The LC-MS/MS method was used to determine the concentration of cyadox in human liver cells.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 271.23 g/mol
• Formule: C₁₂H₉N₅O₃
• Degré de pureté: Min. 95%